BANGALORE: Rohan Ganesh, 5, a brain tumour patient whose right side of the body was paralysed, was expected to die six months after the disease was diagnosed.
Surviving against doctors' prediction, he continued to live for more than four years and was cured of the paralysis.
The technology that rescued him was quantum magnetic resonance (QMR) therapy. It was innovated by Rtd Wing Commander V G Vasishta, founder and CEO of SBF Healthcare Pvt Ltd.
The therapy has been useful to several such terminally ill cancer and arthritis patients. More than 2,000 patients have been treated using the therapy in the last two years.
For terminally ill cancer patients, a new palliative treatment was unveiled on Saturday by Rtd wind commander Rakesh Sharma and police commissioner Shankar Bidari -- the equipment is called AKTIS and it's an improved version of the QMR machine.
"We've failed in all walks of life because we've neglected research. There is a need to encourage original research," Bidari said. Echoing his views, Rakesh Sharma added, "It's rare to find a successful innovation and it's sure to resonate across the globe."
As a principal investigator in clinical trials using QMR therapy for osteoarthritis at the Institute of Aerospace Medicine, Vasishta has been instrumental in designing and implementing this therapy.
Cancer trials were done at the institute from 2004 to 2006. During the trail, 60% patients exposed to QMR therapy showed increase in quality of life span.
At SBF, arthritis patients are offered 21 days treatment and cancer patients 28 days. "Exposure to QMR beams for an hour a day, going for 28 days, normalizes the cell membrane potential to its resting state. This prevents mitosis of cancer cells, and QMR beams counter angiogenesis, cutting down nutritional supply to the tumour tissue," Vasishta explained.
Based on results of the trials, AKTIS has been developed to provide palliative care to cancer patients. Also, the non-invasive technique is a better alternative to knee replacement for osteoarthritis patients.
With present options of treatment such as surgery and chemotherapy resulting in partial cure and side effects for cancer patients, QMR therapy has evolved as a safer option for terminally ill cancer patients.
Surviving against doctors' prediction, he continued to live for more than four years and was cured of the paralysis.
The technology that rescued him was quantum magnetic resonance (QMR) therapy. It was innovated by Rtd Wing Commander V G Vasishta, founder and CEO of SBF Healthcare Pvt Ltd.
The therapy has been useful to several such terminally ill cancer and arthritis patients. More than 2,000 patients have been treated using the therapy in the last two years.
For terminally ill cancer patients, a new palliative treatment was unveiled on Saturday by Rtd wind commander Rakesh Sharma and police commissioner Shankar Bidari -- the equipment is called AKTIS and it's an improved version of the QMR machine.
"We've failed in all walks of life because we've neglected research. There is a need to encourage original research," Bidari said. Echoing his views, Rakesh Sharma added, "It's rare to find a successful innovation and it's sure to resonate across the globe."
As a principal investigator in clinical trials using QMR therapy for osteoarthritis at the Institute of Aerospace Medicine, Vasishta has been instrumental in designing and implementing this therapy.
Cancer trials were done at the institute from 2004 to 2006. During the trail, 60% patients exposed to QMR therapy showed increase in quality of life span.
At SBF, arthritis patients are offered 21 days treatment and cancer patients 28 days. "Exposure to QMR beams for an hour a day, going for 28 days, normalizes the cell membrane potential to its resting state. This prevents mitosis of cancer cells, and QMR beams counter angiogenesis, cutting down nutritional supply to the tumour tissue," Vasishta explained.
Based on results of the trials, AKTIS has been developed to provide palliative care to cancer patients. Also, the non-invasive technique is a better alternative to knee replacement for osteoarthritis patients.
With present options of treatment such as surgery and chemotherapy resulting in partial cure and side effects for cancer patients, QMR therapy has evolved as a safer option for terminally ill cancer patients.
No comments:
Post a Comment